Not all patients want or can be treated with Bariatric surgery, medication can therefore be a good alternative or when needed a supplementary treatment to surgery.
In addition to Bariatric surgeries we offer Wegovy (Semaglutide) as a treatment for obesity at Klinikin. Wegov is a medication that was originally developed for the treatment of type 2 diabetes. However, it has shown promise as a weight loss treatment in recent studies. The brand name for the weight loss formulation of semaglutide is Wegovy.
Wegove (Semaglutide):
Class of Medication: Wegovy belongs to the class of medications known as GLP-1 receptor agonists.
Primary Use: Originally developed for the treatment of type 2 diabetes, Wegovy works by mimicking the action of a hormone called GLP-1, which helps regulate blood sugar levels. In addition to its use in diabetes, it has also been found to be effective in promoting weight loss.
Administration: Wegovy is administered as a subcutaneous injection, typically once a week. The injection is given under the skin, usually in the abdomen or thigh.
Weight Loss Effects: While Semaglutide was initially designed for diabetes management, it has shown significant weight loss benefits in clinical trials. The exact mechanism leading to weight loss is not fully understood, but it is believed to involve a combination of reduced appetite and a slowing of stomach emptying.
Safety Considerations: As with any medication, Wegovy has potential side effects, including gastrointestinal issues (nausea, diarrhea), injection site reactions, and, rarely, pancreatitis.
